Last reviewed · How we verify
NCT07532382
Personalized Stories for Pediatric Kidney Recipients
trial testing AI-generated story in Kidney Transplant in 100 participants. Currently enrolling.
1 December 2026
Quick facts
| Lead sponsor | Paris Translational Research Center for Organ Transplantation |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 March 2026 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- AI-generated story
- AI generated story
Conditions studied
- Kidney Transplant — all drugs for Kidney Transplant →
Sponsor
Paris Translational Research Center for Organ Transplantation — full company profile →
Who can join
Adults 5 to 12, any sex, with Kidney Transplant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pediatric kidney transplant recipients often face major psychosocial challenges that are difficult to address with existing tools. This study evaluates whether clinically supervised AI can generate personalized, age-adapted therapeutic stories for these children and their families.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07532382
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Transplant
Currently open trials in the same condition.
- NCT07348458 — Kidney Protective Jacket · NA · recruiting
- NCT07333495 — A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-c · recruiting
- NCT06919003 — Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE · Phase 2 · recruiting
- NCT07205692 — Multimorbidity and Cardiovascular Risk Factors After Renal Transplant · recruiting
- NCT06833463 — Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients · recruiting
Other Paris Translational Research Center for Organ Transplantation trials
Trials by the same sponsor.
- NCT07091214 — Molecular Transcriptomics in Diagnosing Pediatric Kidney Transplant Rejection: the PANDA-Kids-ATLAS Study · not yet recruiting
- NCT06496269 — Impact of Microvascular Inflammation on Kidney Allograft Outcome · completed
- NCT07269275 — HLA Eplet Mismatches to Predict Long-term Kidney Transplant Outcomes · completed
- NCT06436586 — Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection · completed
- NCT06436027 — Molecular Diagnosis of Heart Allograft Rejection Using Intra-Graft Targeted Gene Expression Profiling. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07532382 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Paris Translational Research Center for Organ Transplantation
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07532382.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing